Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 19

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 19
---
 selling stockholder may offer and sell from time to           
 time under this prospectus, including (i) all shares of our Common Stock purchased by such selling stockholder in the Private Placement,   
 (ii) all of the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants purchased by such selling stockholder in the      
 Private Placement, without giving effect to the Beneficial Ownership Limitation, and (iii) certain of the shares of Common Stock issuable  
 upon exercise of the Series A Warrants purchased by such selling for which we currently have sufficient authorized shares of common stock, 
 without giving effect to the Beneficial Ownership Limitation.                                                                              |

| (4) | Assumes that all shares of Common Stock being registered under                                                                        
 the registration statement of which this prospectus forms a part are sold in this offering, and that none of the selling stockholders 
 acquire additional shares of our Common Stock after the date of this prospectus and prior to completion of this offering.             |

| (5) | The shares reported under “Beneficially Ownership Prior                                                                                  
 to this Offering” consist of 1,929,015 shares of Common Stock purchased in the Private Placement by L1 Capital Global Opportunities      
 Master Fund Ltd. (“L1 Capital”) and excludes  1,929,015 shares of Common Stock  (subject to the adjustment                               
 and alternative cashless exercise provisions of the Series A Warrants) underlying the Series A Warrants held by L1 Capital, the exercise 
 of which are subject to receipt of the Stockholder Approval and certain beneficial ownership limitations. 48,804,164 shares of Common    
 Stock issuable upon the exercise of the Series A Warrants held by L1 Capital are not registered for resale in this prospectus because    
 they are subject to Stockholder Approval. David Feldman and Joel Arber are the Directors of L1 Capital. To the extent Mr. Feldman        
 and Mr. Arber are deemed to beneficially own such shares, Mr. Feldman and Mr. Arber disclaim beneficial ownership of these securities.   
 The principal business address of the L1 Capital is 161A Shedden Road, 1 Artillery Court, PO Box 10085, Grand Cayman KY1-1001, Cayman    
 Islands.                                                                                                                                 |

| (6) | The shares reported under “Beneficially Ownership Prior                                                                                    
 to this Offering” consist of 1,929,015 shares of Common Stock purchased in the Private Placement by S.H.N Financial Investments